IVRO
Price
$0.06
Change
-$0.01 (-14.29%)
Updated
May 23 closing price
Capitalization
911.82K
NMTC
Price
$0.62
Change
-$0.00 (-0.00%)
Updated
May 23 closing price
Capitalization
30.86M
76 days until earnings call
Interact to see
Advertisement

IVRO vs NMTC

Header iconIVRO vs NMTC Comparison
Open Charts IVRO vs NMTCBanner chart's image
InVitro International
Price$0.06
Change-$0.01 (-14.29%)
Volume$200
Capitalization911.82K
NeuroOne Medical Technologies
Price$0.62
Change-$0.00 (-0.00%)
Volume$73K
Capitalization30.86M
IVRO vs NMTC Comparison Chart
Loading...
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVRO vs. NMTC commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVRO is a Hold and NMTC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (IVRO: $0.06 vs. NMTC: $0.62)
Brand notoriety: IVRO and NMTC are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IVRO: 0% vs. NMTC: 21%
Market capitalization -- IVRO: $911.82K vs. NMTC: $30.86M
IVRO [@Medical Specialties] is valued at $911.82K. NMTC’s [@Medical Specialties] market capitalization is $30.86M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVRO’s FA Score shows that 1 FA rating(s) are green whileNMTC’s FA Score has 0 green FA rating(s).

  • IVRO’s FA Score: 1 green, 4 red.
  • NMTC’s FA Score: 0 green, 5 red.
According to our system of comparison, IVRO is a better buy in the long-term than NMTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NMTC’s TA Score shows that 5 TA indicator(s) are bullish.

  • NMTC’s TA Score: 5 bullish, 2 bearish.

Price Growth

IVRO (@Medical Specialties) experienced а +3.87% price change this week, while NMTC (@Medical Specialties) price change was -6.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.90%. For the same industry, the average monthly price growth was +5.12%, and the average quarterly price growth was +0.02%.

Reported Earning Dates

NMTC is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Medical Specialties (-0.90% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NMTC($30.9M) has a higher market cap than IVRO($912K). NMTC YTD gains are higher at: -24.579 vs. IVRO (-31.516).
IVRONMTCIVRO / NMTC
Capitalization912K30.9M3%
EBITDAN/A-13.34M-
Gain YTD-31.516-24.579128%
P/E RatioN/AN/A-
RevenueN/A2.82M-
Total CashN/A2.68M-
Total DebtN/A154K-
FUNDAMENTALS RATINGS
IVRO vs NMTC: Fundamental Ratings
IVRO
NMTC
OUTLOOK RATING
1..100
8928
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
997
PRICE GROWTH RATING
1..100
8264
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NMTC's Valuation (59) in the null industry is in the same range as IVRO (75). This means that NMTC’s stock grew similarly to IVRO’s over the last 12 months.

NMTC's Profit vs Risk Rating (100) in the null industry is in the same range as IVRO (100). This means that NMTC’s stock grew similarly to IVRO’s over the last 12 months.

IVRO's SMR Rating (9) in the null industry is significantly better than the same rating for NMTC (97). This means that IVRO’s stock grew significantly faster than NMTC’s over the last 12 months.

NMTC's Price Growth Rating (64) in the null industry is in the same range as IVRO (82). This means that NMTC’s stock grew similarly to IVRO’s over the last 12 months.

IVRO's P/E Growth Rating (96) in the null industry is in the same range as NMTC (100). This means that IVRO’s stock grew similarly to NMTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NMTC
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 5 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGOYX12.53N/A
N/A
Victory Munder Mid-Cap Core Growth Y
OPMCX19.04N/A
N/A
Invesco Main Street Mid Cap C
FIFRX135.51N/A
N/A
Franklin Growth R6
LPFCX5.44N/A
N/A
ALPS Global Opportunity C
FCIRX17.28-0.05
-0.29%
NYLI PineStone International Equity Cl A

IVRO and

Correlation & Price change

A.I.dvisor tells us that IVRO and ECIA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVRO and ECIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVRO
1D Price
Change %
IVRO100%
-16.68%
ECIA - IVRO
20%
Poorly correlated
N/A
NMTC - IVRO
20%
Poorly correlated
+1.12%
IOBCF - IVRO
13%
Poorly correlated
-1.89%
KLYG - IVRO
9%
Poorly correlated
-9.68%
GCTK - IVRO
8%
Poorly correlated
-4.79%
More

NMTC and

Correlation & Price change

A.I.dvisor tells us that NMTC and BSX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NMTC and BSX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMTC
1D Price
Change %
NMTC100%
+1.12%
BSX - NMTC
30%
Poorly correlated
N/A
MMSI - NMTC
25%
Poorly correlated
+0.28%
EKSO - NMTC
24%
Poorly correlated
+0.43%
AZTA - NMTC
24%
Poorly correlated
-3.67%
TMO - NMTC
23%
Poorly correlated
-1.16%
More